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We have developed a method to localize specific sites where RNA elongation is arrested due to DNA- 
bound ligands. The method was used to determine apparent binding sites for actinomycin D. We have 
found 14 strong RNA hindrance sites along nucleotide sequence of T7 and Dlll T7 DNA of 380 
nucleotides full length under low actinomycin D concentration conditions. Nucleotide sequence of all the 
sites is described by general formula XGCY where X $ G and Y $ C. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
Interaction of DNA with ligands capable of 
transcription inhibition has been thoroughly in- 
vestigated (review [l]). The interaction of ac- 
tinomycin D (act.D) with DNA [2] is the best 
studied. Nevertheless, the nucleotide sequence 
most preferable for act.D binding is not known. 
To reveal the sequence we have used the method in 
[3-61 for studying nucleotide sequence dependence 
of RNA elongation rate. We have searched for the 
sequences where RNA elongation is retarded due 
to the presence of act.D. 
2.1. Preparation of ternary complex of RNA 
polymerase with DNA template and labeled 
nascent RNA 
T7 or Dlll T7 DNA (0.1 g/l; 0.13 mM 
This report shows that act.D preferentially inter- 
rupts elongation in the vicinity of the 
tetranucleotide 5 ’ X&Y3 ’ , where X $ G and Y $ C. 
The last nucleotide of the retarded RNA chain is 
either X or G, as indicated by dots above the let- 
ters. Other DNA sequences are also capable of bin- 
ding act.D. However, much higher concentrations 
of act. D are needed to observe RNA elongation 
inhibition at these sites. 
basepairs) was incubated at 20-22°C in 25-100 yl 
mixture containing: buffer A [50 mM Tris-HCl 
(pH 8.0), 0.1 M KCl, 5 mM MgClz], 2 PM each of 
CTP, GTP, UTP and [~u-~‘P]ATP 
(100-400 Ci/mmol), 0.1 mM CpA, 10 mg/l of E. 
coli RNA polymerase. RNA synthesis was initiated 
by adding the enzyme and terminated after 6 or 
15 min with 50 mM EDTA. Under the conditions 
employed, RNA synthesis was initiated mostly 
from the Al promoter and the nucleotide sequence 
of nascent RNA is readily followed [3,5]. The ter- 
nary complex containing nascent RNA of 60-160 
nucleotides was purified from free NTPs by gel- 
filtration through a 14 x 0.3 cm A-1.5 m agarose 
gel column equilibrated with buffer A [4]. 
2.2. RNA chain elongation andpyrophosphorolysis 
The ternary complex was incubated with 
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I-1OpM a&D for 30 min at 20°C. The complex 
was then divided into 5-10~1 portions and 
0.5 mM Na4P207 or a mixture of 0.5 mM of each 
of the 4 unlabelled NTPs were added to initiate 
reactions. Both reactions were terminated with 
50 mM EDTA. 
2.3. Nascent RNA sequencing with 
3 ‘-UCH3-NTPs 
This was done as in [3,4]. To terminate RNA at 
Fig.1. Inhibition of DIII T7 RNA elongation by act.D. 
Autoradiography of 13’P]RNA after electrophoresis in 
20% polyacrylamide gel: (A) original ternary complex 
synthesized for 6 min from DIII T7 DNA; (B,E,H) the 
ternary complex the same as in (A) incubated with 
0.5 mM of unlabelled NTPs for 10 s, 30 s and 30 min, 
respectively; (C,F,I) the same as (B,E,H), but before 
NTP addition the ternary complex was incubated with 
1 ,LLM act.D for 30 min; (D,G,J) the same as (C,F,I), but 
at 10 /tM act.D. Nucleotides are numbered starting from 
the initiating dinucieotide CpA. Indicated numbers 
correspond to the 3’-terminal nucleotide residues of 
retarded RNAs. 
a certain nucleotide, ’ 100/1M each of the 4 
3 ’ -OCH3-NTPs were added to the 4 separated 5 /cl 
samples at 6-8 min of the [32P]RNA synthesis 
reaction. The nucleotide sequence was in agree- 
ment with DNA sequence of T7 [7]. Elec- 
trophoresis conditions and other experimental 
details are described in [3,5]. 
3 .RESULTS 
3.1. Location of RNA chain elongation hindrance 
sites 
Distribution of the nascent RNA length in the 
original ternary complexes is shown in fig.lA, 2A 
and 3H. The complexes were used as starting 
A B C D E 
Fig.2. Influence of act.D on DIII T7 RNA elongation 
and pyrophosphorolysis. Autoradiography of [32P]RNA 
after electrophoresis in lS70 polyacrylamide gel: (A) 
initial ternary complex synthesized for 15 min; (B,C) 
RNA pyrophosphorolysis for 1 and 20 min, respectively; 
(D,F) as (B,C) but in the presence of 10pM act-D for 1 
and 20 min, respectively; (E,G) RNA elongation at 
IOpM act.D for 1 and 20 min, respectively; (H-K) RNA 
sequencing with 3 ‘-OCHj-CTP, 3’-OCH3-GTP, 
3 ’ -OCH3-ATP and 3 ’ -OCHs-UTP, respectively. 
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Fig.3. Inhibition of T7 RNA elongation by act.D. 
Autoradiography of [“P]RNA after electrophoresis in 
20% polyacrylamide gel: (H) initial ternary complex 
synthesized for 6 min; (I-K) RNA was elongated with 
0.5 mM of unlabelled NTP without act.D for 30 s, 
2 min and 30 min, respectively; (E-G) RNA was 
elongated with 0.5 mM of unlabelled NTP in the 
presence of 1OpM act.D for 30 min, 2 min and 30 s, 
respectively; (A-D) RNA sequencing with 
3’-OCH3-UTP, 3’-OCHs-ATP, 3’-OCHs-GTP and 
3 ’ -OCHs-CTP, respectively. 
material for these act.D experiments. The features 
of the distribution of RNA lengths in the ternary 
complexes have been discussed [5,6]. 
Addition of concentrated unlabelled NTPs to 
the original ternary complex results in fast RNA 
elongation and consequently in redistribution of 
the radioactivity to the upper part of the gel, as one 
can see comparing fig.lB,E,H or fig.31-K with 
fig.lA and fig.3H, respectively. In the presence of 
act.D new bands (fig.lC,D,F,G,I,J; fig.3E-G) 
corresponding to RNA lengths from nucleotides 
40-200 appear. Most of the new bands differ from 
those present in the original complexes and ternary 
complexes elongated in the absence of act.D 
A 
I 
CCACAC~~C~~A~GGGG~AACCGUAUGUA~ACCUGA~GGGUU~G~AAUGAAACAACGAAU 
40 50 60 70 80 90 
CGAA~GCCUUA~UGAACUCC~oUUAACCGCAAGAUUAACAAGAUAGGUUCC~~CUA 100 I 110 I -130 I 140 150 
UGACAGAACG~ACU~~~GGCUUAAAGAAAGGUUAUA~G~~CAAU~~CACACUAUA~~~GCUG 160 - I 170 180 190 200 I I 
C~AAUC~hGAAUAGUGACAACUU~~CG 
220 230 240 
B 
CGASACCGGGGUCAAC~GGAUAAGUAGAC~GCCUGAUAAGUCGCACGAAAAA~AG~UAUU 
- 40 50 60 70 80 90 
I I I 
GACAACAUGAAGUAACAUGCAGUAAGAUACAAAUCGCU~GGUAACACUAGCAGCGUCAAC 
- 100 110 120 To-- 140 --150 
~GGG~~CAGUGC~UUCUAGGUGA~~~AAG~G~ACCA~GGC I 170 180 1 I 190 
Fig.4. RNA elongation hindrance sites along primary structure of DIII T7 RNA (A) and T7 RNA (B). Bold lines above 
letters denote the location of 3 ‘-ends of RNAs retarded at 1 yM of act.D and 30 s elongation time. Consensus sequences 
are underlined. Dots above letters denote the 3’-ends of RNAs retarded at > 10 /tM act.D. 
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(fig.lA and B,E,H; fig.3H and I-K). These new 
bands correspond to the RNA retarded by act.D 
and therefore, point to the sites occupied by act.D 
molecules. Positions of these bands are not altered 
when RNA elongation time varies from 
10 s-30 min or [act.D] varies from 1-10pM 
(fig.l,3). Location of the sites of elongation hin- 
drance are determined via sequencing the nascent 
RNA (fig.2H-K; fig.3A-D). Fig.4 shows the posi- 
tions of the sites along nucleotide sequences of the 
RNAs analyzed. When [act.D] is > 1OpM ([DNA] 
being 130yM nucleotide basepairs), a number of 
additional bands appear. Some of them (positions 
47,64, 70, 71 in fig.lD,G; and 100, 151, 152, 222, 
240 in fig.ZG) are already visible as weak bands at 
10 PM act.D. At higher [act.D] their intensities in- 
crease. At 1OOpM act.D they become as intense as 
the strong bands at < 10 PM act.D. Positions of all 
the additional bands are pointed out in fig.4. 
3.2. ~yroph~sp~#ro~ysis of RNA in the presence 
of act.D 
Results shown in fig.2D,F compared with those 
in fig.2B,C clearly indicate that act.D is not able to 
inhibit the pyrophosphorolysis reaction [4]. It is 
worth noting that the antibiotic olivomycin shows 
the ability to specifically inhibit both RNA elonga- 
tion and the p~ophosphorolysis reaction 
(submitted). 
4. DISCUSSION 
4.1. Consensus sequence for strong hindrance 
sites 
Every prominent elongation hindrance site for 
low act.D concentrations is situated within a 
generalized sequence 5 ’ XGCY 3 ’ (fig.4). For short 
incubation times with high NTP concentrations 
(fig. IC,D) RNA is predominantly terminated with 
X. For longer incubation times (fig.li,J) one GMP 
residue is slowly added and the last RNA 
nucleotide becomes either X or G. It is of interest 
that the rate of the GMP incorporation is by 
several orders of magnitude lower than that of free 
RNA elongation under the conditions used. 
Table 1 summarizes all elongation hindrance 
sites visible at <5 FM act.D with their location in 
the RNA sequences vs the associated 
tetranucleotide. Frequencies of occurrence of the 
tetranucleotide and the hindrance sites are also in- 
Table 1 
A list of RNA elongation hindrance sites 
5 ‘XGCY3 ’ N n Position of elongation 
hindrance sites 
CGCA 
UGCG 
UGCA 
CGCU 
AGCG 
AGCA 
UGCU 
CGCC 
GGCG 
UGCC 
GGCA 
AGCC 
GGCU 
CGCG 
GGCC 
AGCU 
7 7 
0 0 
2 2 
2 2 
3 2 
1 1 
0 0 
1 0 
2 0 
2 0 
2 0 
1 0 
2 0 
0 0 
0 0 
0 0 
77-80, 117-120, 126-129, 
163-166 of DIII T7 RNA 
77-80, 159-162, 186-189 
of T7 RNA 
213-216 of DIII T7 RNA, 
112-115 of T7 RNA 
210-213 of DIII T7 RNA, 
129-132 of T7 RNA 
106-109 of DIII T7 RNA, 
146-149, 184-187 of T7 RNA 
143-145 of T7 RNA 
99-102 of DID T7 RNA 
239-242 of DIII T7 RNA, 
157-160 of T7 RNA 
191-194 of DIII T7 RNA, 
166-169 of T7 RNA 
50-53, 199-202 of DIII T7 RNA 
64-67 of T7 RNA 
150-153, 172-175 of 
DID T7 RNA 
Complementary tetranucleotides are combined in pairs: 
N, occurrence frequency of the tetranucleotides in RNA 
fragment in fig.4; n, frequency of hindrance sites 
associated with tetranucleotide 
dicated. One can see that any time RNA 
polymerase meets XGCY, if X $ G and Y $ C, RNA 
synthesis is interrupted by act.D. There is only one 
exception: AGCG situated between nucleotides 
146-149 of T7 RNA seems to be unable to stop 
RNA elongation (fig.4). Here, however, the site is 
overlapped with AGCA located 3 nucleotides 
upstream. 
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Some of the probable hindrance sites UGCG, both RNA - DNA hybrid and single-stranded 
UGCU, AGCU and CGCG did not happen to oc- DNA, the finding raises a number of questions on 
cur in the T7 RNAs analyzed (table 1). the mechanism of RNA synthesis. It is of interest 
Tetranu~leotides UGCG and IJGCU are found in that another powerful inhibitor of RNA elonga- 
transcripts of pBRS 2950 [S] initiated from cloned tion, olivomycin, interrupts elongation 3-4 
T7 A3 promoter. These two tetranucleotides are nucleotides upstream the apparent binding se- 
found to be the sites of strong inhibition of RNA quence which is any of trinucleotides GGG, CGG 
elongation by a&D (not shown}. or GGC (submitted). 
The probability of occurrence of the concensus 
sequence (if correct) in random DNA sequence 
with 50% GC content is equal to 0.036, which pret- 
ty well agrees with the value found in the experi- 
ment: 14 sites/380 nucleotides = 0.037 (fig.4). 
We have shown in this paper that act.D binding 
constant depends on DNA nucleotide sequence 
and therefore, interpretation of binding isoterms 
[2] needs reevaluation. 
4.2. Other ~i~dr~~ce sites 
When the sites described in the previous section 
are saturated when the act.D concentration is in- 
creased, other RNA elongation hindrance sites 
become visible. As far as nucleotide sequence 
specificity is concerned, the sites definitely include 
all the XGCY with X = G or Y = C excluded from 
the strong hindrance sites. In addition some unique 
hindrance sites appear in the same range of 
[act.D]: UGGG, CGGG, C4cc and GAGG 
(fig.4). No general formula for these sites can be 
drawn from the data obtained, but it seems that a 
single G or a dinu~leotide CG is not sufficient to 
induce act.D binding. When transcription of DIII 
T7 DNA is inhibited with 1OOpM act.D rather 
wide guanine-containing regions are still apparent- 
ly free of act.D: these are for instance regions from 
nucieotide 80-99 and 127-143 of DIII RNA 
(fig.4). 
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